NASDAQ$TRVI

Trevi Therapeutics Inc · Q3 2023 earnings

Q3 2023 earnings ·

Headline financials

Total Revenue

$0.00

Previous: $0.00
EPS

-$0.08

Previous: -$0.12+33.3%
Capital Expenditures

-$115K

Previous: -$43K-167.4%
Free Cash Flow

-$7.81M

Previous: -$8.31M+6.0%
Net Income

-$7.7M

Previous: -$8.27M+6.9%
Operating Income

-$9.05M

Previous: -$8.41M-7.6%
Gross Profit

$0.00

Previous: $0.00
Cash & Equivalents

$26M

Previous: $66.6M-61.0%
Total Assets

$95.9M

Previous: $128M-25.3%

Revenue & EPS history

Trevi Therapeutics Inc · Revenue · Quarterly

$0

Q3 2023

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 12 quarterly earnings reports · overlaid with Q3 2023

Historical avgQ3 2023

+0.7%

Avg return

Earnings day

-1.3%

Avg return

5 days after

+8.6%

Avg return

30 days after

42%

5 / 12 earnings

Positive

+8.1%

Q2 2024

Best reaction

-4.5%

Q4 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+2.0%+0.9%-3.1%
Q4 2025-4.5%-3.8%+36.1%
Q3 2025-3.3%-4.6%+7.8%
Q1 2025-0.9%-3.1%+6.0%
Q3 2024+2.6%+1.7%-8.6%
Q2 2024+8.1%+4.2%+13.9%
Q1 2024-1.4%-7.1%-16.0%
Q3 2023+0.0%-6.0%-16.1%
Q2 2023+4.8%+3.5%+0.4%
Q1 2023+0.0%-2.2%+85.9%
Q3 2022+0.0%+14.0%+20.7%
Q2 2022+0.2%-13.1%-23.7%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro